Urticaria Management

Urticaria Management centers on the structured evaluation and treatment of acute and chronic hives, a condition characterized by transient wheals, pruritus, and sometimes angioedema. Although individual lesions typically resolve within 24 hours, recurrent episodes may persist for months or years, significantly affecting patient quality of life. As a high-impact inflammatory topic discussed at every international Dermatology Conference, this session focuses on systematic diagnosis, trigger identification, and evidence-based therapy escalation. Closely aligned with chronic hives treatment strategies, urticaria management integrates immunology, allergology, and patient-centered care.

The session begins by differentiating acute urticaria from chronic spontaneous urticaria and inducible forms triggered by cold, pressure, heat, or cholinergic stimuli. Understanding these subtypes guides laboratory testing and management pathways. While acute cases often relate to infection or medication exposure, chronic urticaria frequently lacks a clear external trigger and may involve autoimmune mechanisms.

Pathophysiology centers on mast cell activation and histamine release, leading to vascular permeability and dermal edema. Participants will examine how autoantibodies targeting IgE receptors contribute to persistent symptoms in some patients. Identifying red flags such as systemic symptoms or vasculitic features ensures appropriate referral and further investigation.

Therapeutic strategies follow a stepwise approach. Second-generation antihistamines remain first-line therapy, with dose escalation for refractory cases. Biologic agents targeting IgE pathways offer effective options for patients with persistent chronic disease. Short-term corticosteroids may be used during severe flares but are not recommended for long-term control.

Lifestyle guidance includes avoidance of known triggers, stress reduction, and monitoring medication reactions. Patient education is essential, as unpredictability of symptoms can lead to anxiety and reduced daily functioning.

Emerging research into novel biologic targets and immune modulation continues to refine treatment precision. By combining structured diagnostic algorithms with personalized therapeutic plans, clinicians can significantly reduce symptom burden and improve long-term disease control.

This session provides a comprehensive framework for effective urticaria management across acute and chronic presentations.